Pradaxa Lawsuits Increase in January 2014
Pharmaceuticals play an integral role in the well-being of many people. Unfortunately, many have side effects that can cause a great amount of damage, suffering, and even death to the patient. One example is Pradaxa, a blood thinning medication. Pradaxa lawsuits allege that the drug is responsible for an increased chance for uncontrollable internal bleeding. If you believe that you or a loved one has been negatively impacted by Pradaxa, contact the American Injury Attorney Group for a free, no obligation case evaluation today. Should you have an actionable case, we can connect you with an affiliated, experienced attorney for representation.
Pradaxa Lawsuits Bundled And Growing
Lawsuits surrounding medications are often a very complicated, expensive matter that affects a lot of people. A traditional approach would typically involve a class action lawsuit. Pharmaceuticals cases, however, often follow a different path that helps accommodate the difficulties in a better way. They are handled in a special procedure known as Multidistrict Litigation (MDL). In MDL, cases from around the country are transferred to one court for a portion of the proceedings in order to increase efficiency in case handling. Pradaxa lawsuits fall into the category of MDL because of the scope. To learn more about the difference between class action lawsuits and MDL, read on here.
A total of 1,936 Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc. in December, 2013. The new year saw a 6% increase in Pradaxa lawsuits filed with 2,057 new cases added in January, 2013.
The core of the lawsuits is that Pradaxa allegedly facilitates an increased chance for internal bleeding with no recourse. Warfarin (brand name Coumadin) is the medication for which Pradaxa is supposed to be an alternative. Warfarin can cause similar problems for the patient due to its anti-clotting effects. The difference is that a doctor can administer a shot of Vitamin K to counteract the anti-clotting effects of warfarin while Pradaxa has no such reversal measure.
The Alleged Differences Between Warfarin And Pradaxa
The Food and Drug Administration (FDA) ruled Pradaxa to be a safe alternative to warfarin in November of 2012. Increased Pradaxa lawsuits and consumer complaints about the drug have played a large role in the FDA launching an investigation into the claims that are now being made against the medication.
Claims such as:
- Users of Pradaxa may be 5x more likely to bleed enough to cause death due to the anti-clotting effect and no effective countermeasure for that quality. (Institute for Safe Medication Practices)
- A recent study suggests that patients taking any blood thinners may be 55% more likely to experience internal bleeding. (American Gastroenterological Association)
- Pradaxa exceeded the number of deaths of all other medications reported to the FDA in 2011. It also ranked first in total Adverse Reaction reports. (Philadephia Inquirer)
Contact the American Injury Attorney Group Today
People that may have been affected by excessive bleeding while taking Pradaxa should consult with a lawyer as soon as possible. The American Injury Attorney Group can evaluate your circumstances and connect you to an experienced lawyer for representation if applicable. Time is of the utmost importance on legal actions for purposes of fact collecting or potential conflicts with a Statute of Limitations. Contact the American Injury Attorney Group today for your free consultation.